title: Requirement of plasminogen binding to its cell-surface receptor α-enolase for efficient regeneration of normal and dystrophic skeletal muscle.
abstract: Adult regenerative myogenesis is central for restoring normal tissue structure and function after muscle damage. In muscle repair after injury, as in severe myopathies, damaged and necrotic fibers are removed by infiltrating inflammatory cells and then replaced by muscle stem cells or satellite cells, which will fuse to form new myofibers. Extracellular proteolysis mediated by uPA-generated plasmin plays a critical role in controlling inflammation and satellite-cell-dependent myogenesis. α-enolase has been described as plasminogen receptor in several cell types, where it acts concentrating plasmin proteolytic activity on the cell surface. In this study, we investigated whether α-enolase plasminogen receptor plays a regulatory role during the muscular repair process. Inhibitors of α-enolase/plasminogen binding: MAb11G1 (a monoclonal antibody against α-enolase) and ε-aminocaproic acid, EACA (a lysine analogue) inhibited the myogenic abilities of satellite cells-derived myoblasts. Furthermore, knockdown of α-enolase decreased myogenic fusion of myoblasts. Injured wild-type mice and dystrophic mdx mice were also treated with MAb11G1 and EACA. These treatments had negative impacts on muscle repair impairing satellite cell functions in vitro in agreement with blunted growth of new myofibers in vivo. Furthermore, both MAb11G1 and EACA treatments impaired adequate inflammatory cell infiltration and promoted extracellular matrix deposition in vivo, which resulted in persistent degeneration. These results demonstrate the novel requirement of α-enolase for restoring homeostasis of injured muscle tissue, by controlling the pericellular localization of plasmin activity.
authors.affiliation: IDIBELL-Institut d'Investigacions Biomèdiques de Bellvitge, Biological Clues of the Invasive and Metastatic Phenotype Research Group, L'Hospitalet de Llobregat, Barcelona, Spain.
authors.forename: Àngels
authors.initials: À
authors.lastname: Díaz-Ramos
authors.forename: Anna
authors.initials: A
authors.lastname: Roig-Borrellas
authors.forename: Ana
authors.initials: A
authors.lastname: García-Melero
authors.forename: Ana
authors.initials: A
authors.lastname: Llorens
authors.forename: Roser
authors.initials: R
authors.lastname: López-Alemany
mesh_terms: D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D005341:Fibrinolysin / Q000378:metabolism; D051379:Mice; D024510:Muscle Development; D018482:Muscle, Skeletal / Q000502:physiology*; D032446:Myoblasts / Q000201:enzymology / Q000502:physiology; D010751:Phosphopyruvate Hydratase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D010958:Plasminogen / Q000378:metabolism*; D011485:Protein Binding; D012038:Regeneration / Q000187:drug effects
chemical_list: D000614:Aminocaproates; D010958:Plasminogen; D005341:Fibrinolysin; D010751:Phosphopyruvate Hydratase